Hemokinins and endokinins

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cellular and Molecular Life Sciences (CMLS)

• Publication date

  2004-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00018-004-4035-xPMID 15224188PMCID PMC11138928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Risk of Sudden Cardiac Arrest in Obstructive Pulmonary Disease: A Case-Control Study

  2013cited by this paper
• Expertentreffen obstruktive Atemwegserkrankungen: Kardiovaskuläre Aspekte der COPD

  2013cited by this paper
• Statins, systemic inflammation and risk of death in COPD: the Rotterdam study.

  2013cited by this paper
• Effect of ticagrelor on pulmonary function in healthy elderly volunteers and asthma or chronic obstructive pulmonary disease patients

  2013cited by this paper
• Macrolides for the long‐term management of asthma – a meta‐analysis of randomized clinical trials

  2013cited by this paper
• Potential Role of Endogenous Adenosine in Ticagrelor‐Induced Dyspnea

  2013cited by this paper
• Use of azithromycin and death from cardiovascular causes.

  2013cited by this paper
• Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial.

  2013cited by this paper
• Cardiovascular risks with azithromycin and other antibacterial drugs.

  2013cited by this paper
• Cardiovascular safety in patients receiving roflumilast for the treatment of COPD.

  2013cited by this paper
• Azithromycin and the risk of cardiovascular death.

  2012cited by this paper
• Resting heart rate is a predictor of mortality in COPD

  2012cited by this paper
• Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort.

  2012cited by this paper
• Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes.

  2012cited by this paper
• Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study.

  2012cited by this paper
• Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.

  2012cited by this paper
• Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.

  2012cited by this paper
• Drug safety in COPD revisited: what is the number needed to analyze?

  2012cited by this paper
• Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study

  2011cited by this paper
• Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD.

  2011cited by this paper
• Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy).

  2011cited by this paper
• Azithromycin for prevention of exacerbations of COPD.

  2011cited by this paper
• Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

  2011cited by this paper
• Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.

  2010cited by this paper
• Cardiovascular events associated with ipratropium bromide in COPD.

  2010cited by this paper
• The safety of tiotropium--the FDA's conclusions.

  2010cited by this paper
• Cardiovascular safety of tiotropium in patients with COPD.

  2010cited by this paper
• Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD

  2009cited by this paper
• Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

  2009cited by this paper
• Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study

  2008cited by this paper
• Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports.

  2008cited by this paper
• Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2008cited by this paper
• Telmisartan, ramipril, or both in patients at high risk for vascular events.

  2008cited by this paper
• Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension

  2008cited by this paper
• Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.

  2008cited by this paper
• Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.

  2008cited by this paper
• Role of macrolide therapy in chronic obstructive pulmonary disease

  2008cited by this paper
• Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.

  2008cited by this paper
• Cardiac safety of formoterol 12 microg twice daily in patients with chronic obstructive pulmonary disease.

  2007cited by this paper
• Statin use reduces decline in lung function: VA Normative Aging Study.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension.

  2006cited by this paper
• Corticosteroids and the risk of atrial fibrillation.

  2006cited by this paper
• Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.

  2006cited by this paper
• Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.

  2006cited by this paper
• Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge

  2006cited by this paper
• beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease.

  2005cited by this paper
• Cardioselective beta-blockers for chronic obstructive pulmonary disease.

  2005cited by this paper
• Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature.

  2004cited by this paper
• Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis.

  2004cited by this paper
• Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

  2004cited by this paper
• Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease.

  2004cited by this paper
• Cardiovascular safety of salmeterol in COPD.

  2003cited by this paper
• Valsartan-Induced Angioedema

  2003cited by this paper
• T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis.

  2003cited by this paper
• Inhaled short acting β agonist use in COPD and the risk of acute myocardial infarction

  2003cited by this paper
• Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.

  2003cited by this paper
• Characterization of the endokinins: Human tachykinins with cardiovascular activity

  2003cited by this paper
• Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction.

  2003cited by this paper
• Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.

  2002cited by this paper
• Hospitalizations and mortality in the Lung Health Study.

  2002cited by this paper
• Identification, localization and receptor characterization of novel mammalian substance P-like peptides.

  2002cited by this paper
• Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.

  2002cited by this paper
• The Tachykinin Peptide Family

  2002cited by this paper
• Efficacy of calcium channel blockers as maintenance therapy for asthma.

  2002cited by this paper
• Pharmacological profile of hemokinin 1: a novel member of the tachykinin family.

  2002cited by this paper
• Pharmacological profile of the novel mammalian tachykinin, hemokinin 1

  2002cited by this paper
• Neurokinin B Induces Oedema Formation in Mouse Lung Via Tachykinin Receptor‐Independent Mechanisms

  2002cited by this paper
• Precursor convertases in the secretory pathway, cytosol and extracellular milieu.

  2002cited by this paper
• The human tachykinin NK1 (short form) and tachykinin NK4 receptor: a reappraisal.

  2002cited by this paper
• Hemokinin 1 is a full agonist at the substance P receptor

  2001cited by this paper
• A regulatory role for neurokinin B in placental physiology and pre-eclampsia.

  2001cited by this paper
• Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study.

  2001cited by this paper
• Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.

  2001cited by this paper
• μ-Opioid Receptors Often Colocalize with the Substance P Receptor (NK1) in the Trigeminal Dorsal Horn

  2000cited by this paper
• Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis

  2000cited by this paper
• Baseline predictors of tolerability to carvedilol in patients with chronic heart failure

  2000cited by this paper
• Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia

  2000cited by this paper
• Opioid activity of sendide, a tachykinin NK1 receptor antagonist.

  1999cited by this paper
• Life-threatening events after theophylline overdose: a 10-year prospective analysis.

  1999cited by this paper
• Major metabolites of substance P degraded by spinal synaptic membranes antagonize the behavioral response to substance P in rats.

  1999cited by this paper
• Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.

  1998cited by this paper
• The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions

  1998cited by this paper
• Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes.

  1998cited by this paper
• Identification of a δ isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes

  1998cited by this paper
• Angioneurotic edema attributed to the use of losartan.

  1998cited by this paper
• Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis.

  1998cited by this paper
• Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs.

  1997cited by this paper
• Migratory pulmonary infiltrates in a patient treated with sotalol.

  1997cited by this paper
• The dual nature of the tachykinin NK1 receptor.

  1997cited by this paper
• The dual nature of the tachykinin NK1 receptor

  1997cited by this paper
• Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor.

  1996cited by this paper
• Perindopril-associated pneumonitis.

  1996cited by this paper
• Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology.

  1995cited by this paper
• The mammalian tachykinin receptors.

  1995cited by this paper
• Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors

  1994cited by this paper
• Substance P: A competence factor for human fibroblast proliferation that induces the release of growth‐regulatory arachidonic acid metabolites

  1993cited by this paper
• Colocalization of vasoactive substances in the endothelial cells of human umbilical vessels

  1993cited by this paper
• Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.

  1993cited by this paper
• Efficient amidation of C-peptide deleted NPY precursors by non-endocrine cells is affected by the presence of Lys-Arg at the C-terminus.

  1993cited by this paper

• An atlas of genetic determinants of forearm fracture

  2023cites this paper
• Tachykinins, new players in the control of reproduction and food intake: A comparative review in mammals and teleosts

  2022cites this paper
• Female Infertility Is Associated with an Altered Expression Profile of Different Members of the Tachykinin Family in Human Granulosa Cells

  2022cites this paper
• Novel Pituitary Actions of TAC4 Gene Products in Teleost

  2021cites this paper
• Characteristics of Neurokinin-3 Receptor and Its Binding Sites by Mutational Analysis

  2021cites this paper
• Endokinin A/B stimulates rat gastric motility through myogenic NK1 receptors located in fundus.

  2020cites this paper
• Hemokinin-1 Gene Expression Is Upregulated in Trigeminal Ganglia in an Inflammatory Orofacial Pain Model: Potential Role in Peripheral Sensitization

  2020cites this paper
• Mass spectrometric studies on the peptide integrity of substance P and related human tachykinins in human biofluids.

  2020cites this paper
• A design of experiments concept for the minimization of nonspecific peptide adsorption in the mass spectrometric determination of substance P and related hemokinin-1.

  2019cites this paper
• Hemokinin‐1 stimulates C‐C motif chemokine ligand 24 production in macrophages to enhance eosinophilic inflammation in nasal polyps

  2019cites this paper
• MRS and DTI evidence of progressive posterior cingulate cortex and corpus callosum injury in the hyper-acute phase after Traumatic Brain Injury

  2019cites this paper
• Tachykinins and Kisspeptins in the Regulation of Human Male Fertility

  2019cites this paper
• Pharmacological characteristics of hemokinin-1-derived peptides in rat pruriceptive processing.

  2019cites this paper
• Contribution à l'étude de l'effet de la substance P sur la sécrétion d'aldostérone dans la glande surrénale humaine normale

  2018cites this paper
• Short‐ and long‐term gene expression profiles induced by inhaled TiO2 nanostructured aerosol in rat lung

  2018cites this paper
• Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts

  2018cites this paper
• Substance P Receptor in the Rat Heart and Regulation of Its Expression in Long-Term Diabetes

  2018cites this paper
• Hemokinin-1 mediates anxiolytic and anti-depressant-like actions in mice.

  2017cites this paper
• Central distribution sites and protein expression of human HK-1 in mice

  2017cites this paper
• Substance P Regulation in Epilepsy

  2017influential citation
• The effect of intra-articular botulinum toxin A on substance P, prostaglandin E2, and tumor necrosis factor alpha in the canine osteoarthritic joint

  2017cites this paper
• Substance P receptor in the rat indusium griseum during postnatal development.

  2017cites this paper
• Distribution of hemokinin-1 in the rat trigeminal ganglion and trigeminal sensory nuclear complex.

  2017cites this paper
• TRPA1, substance P, histamine and 5-hydroxytryptamine interact in an interdependent way to induce nociception

  2017cites this paper
• Role of hemokinin-1 in health and disease.

  2017cites this paper
• The role of neuropeptides in adverse myocardial remodeling and heart failure

  2017cites this paper
• Role of substance P in the cardiovascular system.

  2016cites this paper
• Roles of Substance P in Gastrointestinal Functions and Neuroimmune Interactions

  2016cites this paper
• Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.

  2016cites this paper
• Evidence of substance P autocrine circuitry that involves TNF-α, IL-6, and PGE2 in endogenous pyrogen-induced fever.

  2016cites this paper
• Expression of Tachykinins and Tachykinin Receptors and Interaction with Kisspeptin in Human Granulosa and Cumulus Cells1

  2016cites this paper
• THE ROLE OF SENSORY NEUROPEPTIDES IN MOUSE MODELS OF NEUROPATHY AND IMMUNE ARTHRITIS

  2015cites this paper
• Analysis of the Expression of Tachykinins and Tachykinin Receptors in the Rat Uterus During Early Pregnancy1

  2015cites this paper
• Membrane‐induced structure of novel human tachykinin hemokinin‐1 (hHK1)

  2015cites this paper
• Liver immune responses to inflammatory stimuli in a diet-induced obesity model of zebrafish.

  2015cites this paper
• Hemokinin-1-derived peptides have antipruritic effects in rats

  2015cites this paper
• Modulation par le récepteur neurokinine-1du mécanisme d’action des immunosuppresseurs chez les cellules T

  2014cites this paper
• Neurokinin B and reproductive functions: "KNDy neuron" model in mammals and the emerging story in fish.

  2014cites this paper
• Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions

  2014cites this paper
• Tachykinin: recent developments and novel roles in health and disease

  2014cites this paper
• Substance P in heart failure: the good and the bad.

  2014cites this paper
• Direct regulation of gonadotropin release by neurokinin B in tilapia (Oreochromis niloticus).

  2014cites this paper
• An amino-terminal fragment of hemokinin-1 has an inhibitory effect on pruritic processing in rats.

  2014cites this paper
• Hemokinin-1(4-11)-Induced Analgesia Selectively Up-Regulates δ-Opioid Receptor Expression in Mice

  2014cites this paper
• Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant

  2014cites this paper
• Hemokinin-1 mediates pruriceptive processing in the rat spinal cord.

  2014cites this paper
• Plasma urotensin II and neurokinin B levels in acute myocardial infarction and stable coronary artery disease

  2014cites this paper
• Extreme Resistance to Hypercapnia-Induced Pulmonary Edema of the African Naked Mole-Rat

  2014cites this paper
• Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model

  2014cites this paper
• THE ROLE OF THE TACHYKININ SYSTEM AND THE ACTIVATION OF SENSORY NERVE ENDINGS IN BOWEL AND AIRWAY INFLAMMATION MODELS

  2014cites this paper
• Neuropeptides in learning and memory.

  2013cites this paper
• New tachykinin peptides and nociception

  2013cites this paper
• Cross transfer effects after unilateral muscle overuse

  2013cites this paper
• Roles of substance P and ATP in the subepithelial fibroblasts of rat intestinal villi.

  2013cites this paper
• Chapter 125 – Tachykinins

  2013cites this paper
• Bilateral increase in expression and concentration of tachykinin in a unilateral rabbit muscle overuse model that leads to myositis

  2013cites this paper
• Role of Tachykinin 1 and 4 Gene-Derived Neuropeptides and the Neurokinin 1 Receptor in Adjuvant-Induced Chronic Arthritis of the Mouse

  2013cites this paper
• Localization and enzymatic activity profiles of the proteases responsible for tachykinin-directed oocyte growth in the protochordate, Ciona intestinalis.

  2012cites this paper
• Effects of endokinin A/B and endokinin C/D on the antinociception properties of hemopressin in mice.

  2012cites this paper
• Cloning and expression of tachykinins and their association with kisspeptins in the brains of zebrafish

  2012cites this paper
• Involvement of tachykinins and NK1 receptor in the joint inflammation with collagen type II-specific monoclonal antibody-induced arthritis in mice.

  2012cites this paper
• Cortical nNOS neurons co-express the NK1 receptor and are depolarized by Substance P in multiple mammalian species

  2012cites this paper
• The induction and effects of Substance P and its receptor in human immune cells and neurons : potential relevance in multiple sclerosis

  2012influential citation
• Neurokinin Bs and neurokinin B receptors in zebrafish-potential role in controlling fish reproduction

  2012cites this paper
• Hemokinin-1 Stimulates Prostaglandin E2 Production in Human Colon through Activation of Cyclooxygenase-2 and Inhibition of 15-Hydroxyprostaglandin Dehydrogenase

  2012cites this paper
• Hemokinin-1 Gene Expression Is Upregulated in Microglia Activated by Lipopolysaccharide through NF-κB and p38 MAPK Signaling Pathways

  2012cites this paper
• Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.

  2011cites this paper
• Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre‐eclampsia later in pregnancy: implications for screening

  2011cites this paper
• Ascidians: New Model Organisms for Reproductive Endocrinology

  2011influential citation
• The N-terminal domain of human hemokinin-1 influences functional selectivity property for tachykinin receptor neurokinin-1.

  2011cites this paper
• Expression and proliferative effect of hemokinin-1 in human B-cells.

  2011cites this paper
• Effects of endokinin A/B, endokinin C/D, and endomorphin-1 on the regulation of mean arterial blood pressure in rats.

  2011cites this paper
• Pharmacological characteristics of endokinin C/D-derived peptides in nociceptive and inflammatory processing in rats.

  2011cites this paper
• Early B-cell factor regulates the expression of Hemokinin-1 in the olfactory epithelium and differentiating B lymphocytes.

  2011cites this paper
• Distinct differences in tachykinin gene expression in ulcerative colitis, Crohn’s disease and diverticular disease: a role for hemokinin‐1?

  2011cites this paper
• Neurochemistry of Endogenous Antinociception

  2011cites this paper
• Impact of mutations in kisspeptin and neurokinin B signaling pathways on human reproduction.

  2010cites this paper
• Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link.

  2010cites this paper
• Targeted deletion of the tachykinin 4 gene (TAC4-/-) influences the early stages of B lymphocyte development.

  2010cites this paper
• Expression and function of human hemokinin-1 in human and guinea pig airways

  2010influential citation
• Effects of Endokinin A/B and Endokinin C/D on the antinociception of Endomorphin-1 in mice.

  2010cites this paper
• Autocrine regulation of human sperm motility by tachykinins

  2010influential citation
• Effects of Endokinin A/B and Endokinin C/D on the modulation of pain in mice.

  2010cites this paper
• Targeted deletion of the tachykinin 4 gene ( TAC 4-/-) influences the early stages of B lymphocyte development Running title : HK-1 influences early stages of B cell development

  2010cites this paper
• Neurokinin B and urotensin II levels in pre-eclampsia

  2010cites this paper
• Neuropeptides, Hormone Peptides, and Their Receptors in Ciona intestinalis: An Update

  2010influential citation
• Subcutaneous injection of endokinin C/D attenuates carrageenan-induced inflammation.

  2010cites this paper
• Blockade of Tachykinin NK1/NK2 Receptors in the Brain Attenuates the Activation of Corticotrophin‐Releasing Hormone Neurones in the Hypothalamic Paraventricular Nucleus and the Sympathoadrenal and Pituitary‐Adrenal Responses to Formalin‐Induced Pain in the Rat

  2010cites this paper
• The amino-terminal region of hemokinin-1 regulates the induction of thermal hyperalgesia in rats.

  2010cites this paper
• Immunochemical methods for the peptidomic analysis of tachykinin peptides and their precursors.

  2010cites this paper
• Differential effects of substance P or hemokinin-1 on transient receptor potential channels, TRPV1, TRPA1 and TRPM8, in the rat.

  2010cites this paper
• The role of substance P in experimental intracerebral haemorrhage.

  2010cites this paper
• Contribution of tachykinin and kinin receptors in central autonomic control of blood pressure and behavioural activity in hypertensive rats

  2010cites this paper
• Effects of rat/mouse hemokinin-1, human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on rate and perfusion pressure in the isolated guinea pig heart.

  2010cites this paper
• Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation.

  2010influential citation
• Hemokinin-1 Activates the MAPK Pathway and Enhances B Cell Proliferation and Antibody Production

  2010cites this paper
• Antibody Production and Enhances B Cell Proliferation and Hemokinin-1 Activates the MAPK Pathway

  2010cites this paper
• Cough sensors. IV. Nicotinic membrane receptors on cough sensors.

  2009cites this paper
• In vitro characterization of the effects of rat/mouse hemokinin-1 on mouse colonic contractile activity: a comparison with substance P.

  2009cites this paper
• The Regulation of Expression of Hemokinin-1

  2009influential citation